AJG

Arthur J. Gallagher is a top-tier, durable insurance brokerage franchise, and the headline GAAP figures understate it. Reported diluted EPS fell 11.7% to $5.74, but the MD&A makes clear this is optical: the drag is intangible amortization ($2.57/share), acquisition integration, workforce/lease termination and transaction-related costs in the corporate segment — the fingerprints of a large, M&A-heavy year. On an adjusted basis EPS rose 6% to $10.69, brokerage organic revenue grew 6% and brokerage adjusted EBITDAC margin expanded 145 bps to 36.5%. Reported revenue of $13.9B (+20.7%) reflects both that organic growth and a big acquisition spend, and the recurring, commission-based, low-capital-intensity model is exactly the kind of business that holds up through a downturn.

The catch is valuation and the cost of the growth engine. At $214.06 the stock trades at 37.3x GAAP EPS and ~20x adjusted EPS ($214.06 / $10.69) at a 3.9x sales — a premium that already discounts the quality and the steady mid-single-digit organic story. Returns look thin on the surface: ROE is just 6.4% and net margin 10.7%, both depressed by a goodwill-heavy equity base ($23.3B) and amortization from serial acquisitions. The balance sheet is acceptable (liabilities/equity 2.03x, long-term debt $12.1B down 4.9%), but cash collapsed 90.7% to $1.40B and operating cash flow fell 25.3% to $1.93B as capital was funneled into the acquisition program — a reminder that the compounding depends on continuously buying, integrating and financing deals.